Suppr超能文献

丙型肝炎病毒 3a 基因型 NS5A 蛋白的遗传多样性及其与治疗反应的关系。

Genetic diversity of NS5A protein from hepatitis C virus genotype 3a and its relationship to therapy response.

机构信息

Butantan Institute, Viral Immunology Laboratory, Av Vital Brasil n degrees 1500, CEP 05503-900, Butantã, São Paulo, SP, Brazil.

出版信息

BMC Infect Dis. 2010 Feb 23;10:36. doi: 10.1186/1471-2334-10-36.

Abstract

BACKGROUND

The quasispecies nature of HCV may have important implications for viral persistence, pathogenicity and resistance to antiviral agents. The variability of one of the viral proteins, NS5A, is believed to be related to the response to IFN therapy, the standard treatment for infection. In this study we analyzed the quasispecies composition of NS5A protein in patients infected with HCV genotype 3a, before IFN therapy.

METHODS

Viral RNA was isolated from samples of 12 patients: four sustained virological responders (SVR), four non-responders (NR), and four end-of-treatment responders (ETR). cDNA was synthesized, the NS5A region was amplified and the fragments obtained were cloned. Fifteen clones from each patient were sequenced with eight primers, generating 179 contigs.

RESULTS

Higher values for substitution (either synonymous or non-synonymous) and for distance were found in the SVR group. However, the NR group showed relatively more non-synonymous mutations than the other groups, owing to the higher values of dN/dS in complete NS5A and most specific regions. Overall, NS5A protein is undergoing purifying selection, since all dN/dS ratios values are below 0.5.

CONCLUSIONS

Our study provides an overview of the genetic variability of complete NS5A protein in HCV genotype 3a.

摘要

背景

HCV 的准种性质可能对病毒的持续性、致病性以及对抗病毒药物的耐药性具有重要影响。人们认为一种病毒蛋白 NS5A 的变异性与 IFN 治疗的反应(HCV 的标准治疗方法)有关。在这项研究中,我们分析了感染 HCV 基因型 3a 的患者在 IFN 治疗前 NS5A 蛋白的准种组成。

方法

从 12 名患者的样本中提取病毒 RNA:4 名持续病毒学应答者(SVR)、4 名无应答者(NR)和 4 名治疗结束时应答者(ETR)。合成 cDNA,扩增 NS5A 区域,并对获得的片段进行克隆。对每个患者的 15 个克隆进行 8 个引物测序,生成 179 个连续序列。

结果

SVR 组的替换(同义或非同义)和距离值较高。然而,NR 组的非同义突变相对较多,这归因于完整 NS5A 和大多数特定区域的 dN/dS 值较高。总体而言,NS5A 蛋白正在经历纯化选择,因为所有 dN/dS 比值均低于 0.5。

结论

我们的研究提供了 HCV 基因型 3a 中完整 NS5A 蛋白遗传变异性的概述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4a7/2838888/79a00be7828e/1471-2334-10-36-1.jpg

相似文献

2
Analysis of HCV quasispecies dynamic under selective pressure of combined therapy.
BMC Infect Dis. 2013 Feb 1;13:61. doi: 10.1186/1471-2334-13-61.
3
Quasispecies of hepatitis C virus genotype 1 and treatment outcome with peginterferon and ribavirin.
Infect Genet Evol. 2009 Jul;9(4):689-98. doi: 10.1016/j.meegid.2008.11.001. Epub 2008 Nov 21.
6
Sequencing of E2 and NS5A regions of HCV genotype 3a in Brazilian patients with chronic hepatitis.
Mem Inst Oswaldo Cruz. 2010 Feb;105(1):92-8. doi: 10.1590/s0074-02762010000100014.

引用本文的文献

2
Insights From Deep Sequencing of the HBV Genome-Unique, Tiny, and Misunderstood.
Gastroenterology. 2019 Jan;156(2):384-399. doi: 10.1053/j.gastro.2018.07.058. Epub 2018 Sep 27.
4
Analysis of the Enzymatic Activity of an NS3 Helicase Genotype 3a Variant Sequence Obtained from a Relapse Patient.
PLoS One. 2015 Dec 10;10(12):e0144638. doi: 10.1371/journal.pone.0144638. eCollection 2015.
6
On hepatitis C virus evolution: the interaction between virus and host towards treatment outcome.
PLoS One. 2013 Apr 25;8(4):e62393. doi: 10.1371/journal.pone.0062393. Print 2013.
7
Analysis of HCV quasispecies dynamic under selective pressure of combined therapy.
BMC Infect Dis. 2013 Feb 1;13:61. doi: 10.1186/1471-2334-13-61.

本文引用的文献

1
Genetic analysis of hepatitis C virus with defective genome and its infectivity in vitro.
J Virol. 2009 Jul;83(13):6922-8. doi: 10.1128/JVI.02674-08. Epub 2009 Apr 15.
2
Quasispecies of hepatitis C virus genotype 1 and treatment outcome with peginterferon and ribavirin.
Infect Genet Evol. 2009 Jul;9(4):689-98. doi: 10.1016/j.meegid.2008.11.001. Epub 2008 Nov 21.
3
Routine libraries for pattern recognition in quasispecies.
Genet Mol Res. 2008 Sep 30;7(3):970-81. doi: 10.4238/vol7-3x-meeting013.
4
Epidemiology of hepatitis C virus infection.
World J Gastroenterol. 2007 May 7;13(17):2436-41. doi: 10.3748/wjg.v13.i17.2436.
5
Genetic diversity of the hepatitis C virus: impact and issues in the antiviral therapy.
World J Gastroenterol. 2007 May 7;13(17):2416-26. doi: 10.3748/wjg.v13.i17.2416.
6
MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0.
Mol Biol Evol. 2007 Aug;24(8):1596-9. doi: 10.1093/molbev/msm092. Epub 2007 May 7.
7
Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes.
Science. 2006 Jan 13;311(5758):236-8. doi: 10.1126/science.1115030.
8
Trans-complementation of HCV replication by non-structural protein 5A.
Virus Res. 2006 Feb;115(2):122-30. doi: 10.1016/j.virusres.2005.07.012. Epub 2005 Sep 15.
9
Adaptive immune responses in acute and chronic hepatitis C virus infection.
Nature. 2005 Aug 18;436(7053):946-52. doi: 10.1038/nature04079.
10
Evasion of intracellular host defence by hepatitis C virus.
Nature. 2005 Aug 18;436(7053):939-45. doi: 10.1038/nature04078.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验